47.33
+0.62
(1.33%)
After Hours: 47.39
+0.06
(0.13%)
May 23, 7:53PM EDT
NYSE
real-time data -
Disclaimer
Currency in USD
| Range | 46.42 - 47.44 |
| 52 week | 37.02 - 48.79 |
| Open | 46.46 |
| Vol / Avg. | 22.58M/17.10M |
| Mkt cap | 142.92B |
| P/E | 24.12 |
| Div/yield | 0.43/3.63 |
| EPS | 1.96 |
| Shares | 3.02B |
| Beta | 0.34 |
| Inst. own | 75% |
Events
May 28, 2013
Merck & Co., Inc. Annual Shareholder Meeting
- 10:30AM EDT -
May 20, 2013
Merck & Co., Inc. at UBS Global Healthcare Conference -
May 15, 2013
Merck & Co., Inc. at Bank of America Merrill Lynch Health Care Conference -
May 1, 2013
Q1 2013 Merck & Co., Inc. Earnings Conference Call -
Apr 22, 2013
Merck & Co., Inc. at Biotechnology Industry Organization (BIO) International Convention
Apr 12, 2013
Merck & Co at Sanford Bernstein Global Pharmaceuticals "Pipelines Unplugged" Conference Call
Mar 6, 2013
Merck & Co., Inc. at Cowen Health Care Conference -
Feb 27, 2013
Merck & Co., Inc. at Citi Global Healthcare Conference -
|
More events from DailyFinance »
|
Key stats and ratios
| Q1 (Mar '13) | 2012 | |
| Net profit margin | 15.14% | 13.33% |
| Operating margin | 14.53% | 18.49% |
| EBITD margin | - | 47.27% |
| Return on average assets | 6.11% | 5.96% |
| Return on average equity | 12.05% | 11.47% |
| Employees | 82,000 | - |
| Carbon Disclosure Rating | - | 83/100 |
Address
One Merck Drive, P.O. Box 100
WHITEHOUSE STATION, NJ 08889-0100
United States - Map
+1-908-4231000 (Phone)
+1-908-2987082 (Fax)
WHITEHOUSE STATION, NJ 08889-0100
United States - Map
+1-908-4231000 (Phone)
+1-908-2987082 (Fax)
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
About Company - Wikipedia
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
Merck & Co., Inc. (Merck) is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company consists of four operating segments, which are the Pharmaceutical, Animal Health, Consumer Care and Alliances segments, and one reportable segment, which is the Pharmaceutical segment. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Effective February 25, 2013, Dashtag, a unit of Merck & Co Inc's Schering Plough Corp subsidiary acquired 17.95% interest in Fulford (India) Ltd.
Officers and directors
| Kenneth C. Frazier | Chairman of the Board, President, Chief Executive Officer | |
| Peter N. Kellogg | Chief Financial Officer, Executive Vice President | |
| Clark Golestani | Executive Vice President, Chief Information Officer | |
| Michael J. Holston | Executive Vice President, Chief Ethics and Compliance Officer | |
| Bruce N. Kuhlik | Executive Vice President, General Counsel | |
| Mirian M. Graddick-Weir | Executive Vice President - Human Resources | |
| Willie A. Deese | Executive Vice President, President - Merck Manufacturing Division | |
| Richard R. DeLuca Jr. | Executive Vice President, President - Merck Animal Health | |
| Cuong Viet Do | Executive Vice President, Chief Strategy Officer | |
| Bridgette P. Heller | Executive Vice President, President - Merck Consumer Care |